ArticleFujita medical journal2025
Investigating the nutritional status characteristics of terminal cancer patients by the type of cancer.
Article in Fujita medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Patients with terminal cancer experience malnutrition due to cachexia and other problems associated with the disease's progression. Particularly, patients with gastrointestinal cancers often experience malnutrition because of gastrointestinal symptoms; however, there are few reports evaluating nutritional status based on cancer type up to the prediction of prognosis. In the present study, we examined nutritional evaluation and prognosis based on cancer type. Methods: In 2019, 234 patients were admitted to Fujita Health University Nanakuri Memorial Hospital and subsequently died before being discharged. Of these patients, 210 were included in the study. Twenty-four patients who were determined to have refractory cachexia on admission were excluded. The 210 patients were divided into two groups, 94 and 116 patients with gastrointestinal cancers and non-gastrointestinal cancers, respectively. Subsequently, data, such as age, sex, presence or absence of metastasis, whether the cancer was initial or recurrent, serum albumin (Alb) and transthyretin (TTR) levels on admission, and survival time were examined. Moreover, for further analysis, the 94 patients with gastrointestinal cancers were classified into 51 and 43 with hepato-biliary-pancreas cancer and gastrointestinal tract cancers, respectively. Results: Alb and TTR values were significantly lower in patients with gastrointestinal cancer than in patients with non-gastrointestinal cancer (p=0.015 and 0.002, respectively), and Alb values were significantly lower in patients with gastrointestinal tract cancer than in patients with hepato-biliary-pancreas cancer (p=0.049). Conclusion: Patients with terminal cancer having poor nutritional status exhibit poor prognosis. Particularly, among patients with gastrointestinal tract cancer have exceptionally poor nutritional status. Therefore, providing nutritional management that combines intravenous nutrition with appropriate adjustments to each patient's gastrointestinal and absorptive condition is important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.